TetraLogic Pharmaceuticals Initiates Phase 1 Clinical Trial: "TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety ..."
" The Roving Giraffe News Report " provided through
Ace News Service
No comments:
Post a Comment